| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |